DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: MS - RESEARCH AND NEWS
       *****************************************************
       #Post#: 5096--------------------------------------------------
       Vedolizumab and the gut-CNS axis in MS--considering T cell
       licensing pathways
   DIR By: agate
       Date: February 24, 2026, 1:11 am
       ---------------------------------------------------------
       This article includes a "plain language summary" that makes it
       more comprehensible. One of the authors, Olaf Stuve, has been
       very active in MS research for many years.
       From Therapeutic Advances in Neurological Disorders (February
       18, 2026)--"Vedolizumab and the gut-CNS axis in multiple
       sclerosis:  considering T cell licensing pathways":
  HTML https://journals.sagepub.com/doi/full/10.1177/175628642614
       *****************************************************
       Page 1 of 1